The co-founders of PharmEasy—Dharmil Sheth, Dhaval Shah, and Hardik Dedhia—have unveiled their latest venture, All Home, a platform that aims to modernize India’s fragmented home and interior design product industry. Their focus is to provide a one-stop destination for homeowners, architects, and designers across categories like furniture, lighting, kitchenware, and more.
Key Highlights
- What is All Home?
- A curated platform offering a wide range of products in home improvement such as sanitaryware, furniture, kitchen accessories, wardrobes, furnishings, lighting, and hardware.
- Built to address the fragmentation in the Indian interior design and architectural product ecosystem.
- Business Model & Strategy
- All Home partners with profitable, omnichannel home improvement brands.
- It supports these partners with tech enablement, designer insights, and modern manufacturing and distribution strategies powered by the internet.
- The startup was operating in stealth mode for the past six months, during which it achieved operational profitability and scale.
- Brands Already Onboard
- The platform currently features brands like Colour Coats, House of W, and Fiamarc, with plans to add many more soon.
- Founders’ Vision
- In a joint statement, the co-founders said:
“After roti and kapda, India’s next consumer boom lies in ‘makaan’. At All Home, we are building trusted brands for the way India lives, builds, and renovates—across homes, offices, and urban infrastructure.”
- In a joint statement, the co-founders said:
- Funding & Valuation
- All Home has secured an undisclosed investment round led by Bessemer Venture Partners, with a valuation of over $120 million.
- Estimated investment, according to reports, is around $20 million.
- The round included angel investors like Siddharth Shah (PharmEasy), Niket Shah and Shalibhadra Shah (Motilal Oswal), Kabir Narang (B Capital), Ankur Gulati (Warburg Pincus), among others.
- Background Context
- This new venture comes just five months after the trio exited PharmEasy, which is now solely led by Siddharth Shah.
- PharmEasy, once a healthtech unicorn, has seen a decline in both revenue and valuation during FY24, with its FY25 results yet to be made public.
